NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/02/2026
Voltar para busca
Dado oficial do USPTO
AIVIVA BIOPHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
72
Atualização mais recente
17/02/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
20/05/2020
Data de registro
17/02/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/02/2026
Última transação
17/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
06/05/2024
Primeiro uso no comércio
06/05/2024
Código do desenho
5
Tipo de titular
03
Localização do titular
Dover, DE, US
Examinador
JANSON, ANDREW KYLE
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "AIVIVA" having an extended downward line on the first letter "A" and a an extended upward line on the first "V" above the word "BioPharma".
Titulares e representantes
Titulares
AiViva Biopharma, Inc.
Representantes
JOE MCKINNEY MUNCY MUNCY, GEISSLER, OLDS & LOWE, P.C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-dermoinfectives; Anti-friction skin preparations for preventing blisters; Anti-friction skin preparations for preventing chafing; Antibacterial alcohol skin sanitizer gel; Antimicrobials for dermatologic use; Bandages for skin wounds; Dermatological pharmaceutical products; Gelscreams and solutions for dermatological use; Medical cleansers for skin and wounds; Medical preparationsfoothand and skin creams for diabetics; Medicaments for treating skin disorderscancer and prostate related disorder; Medicated balms for treatment of skin; Medicated dermatological preparations and substances; Medicated lotions for treating dermatological conditions; Medicated lotions for skin; Medicated ointments for treating dermatological conditions; Medicated skin preparation for use in treating aberrant wound healing and skin cancer; Non-medicatedtherapeutic skin creams for the treatment of aberrant wound healing and skin cancer; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products for skin care for animals; Preparations for cleansing the skin for medical use; Processed human donor skin for the replacement of soft tissue; Skin grafts; Topical dermatological preparations that treat insect bites and stings
Publicações
Histórico de despachos e eventos da marca no USPTO.
72 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
17/02/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
26/01/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26/01/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/01/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/01/2026
ALIE
ASSIGNED TO LIE
24/01/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/01/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/11/2025
GNRT
NON-FINAL ACTION E-MAILED
20/11/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
20/11/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
20/11/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
13/11/2025
IUAF
USE AMENDMENT FILED
17/09/2025
EISU
TEAS STATEMENT OF USE RECEIVED
17/09/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/09/2025
EX5G
SOU EXTENSION 5 GRANTED
16/09/2025
EXT5
SOU EXTENSION 5 FILED
01/04/2025
EEXT
SOU TEAS EXTENSION RECEIVED
01/04/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/09/2024
EX4G
SOU EXTENSION 4 GRANTED
16/09/2024
EXT4
SOU EXTENSION 4 FILED
16/09/2024
EEXT
SOU TEAS EXTENSION RECEIVED
16/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30/03/2024
EX3G
SOU EXTENSION 3 GRANTED
29/03/2024
EXT3
SOU EXTENSION 3 FILED
29/03/2024
EEXT
SOU TEAS EXTENSION RECEIVED
29/03/2024
IULN
ITU LETTER MAILED, NO RESPONSE REQUIRED
10/10/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30/09/2023
EEXT
SOU TEAS EXTENSION RECEIVED
29/09/2023
EX2G
SOU EXTENSION 2 GRANTED
28/09/2023
EXT2
SOU EXTENSION 2 FILED
28/09/2023
EEXT
SOU TEAS EXTENSION RECEIVED
28/09/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/01/2023
EX1G
SOU EXTENSION 1 GRANTED
09/01/2023
EXT1
SOU EXTENSION 1 FILED
09/01/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/01/2023
DOCK
ASSIGNED TO EXAMINER
13/12/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/10/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
21/08/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
09/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/04/2022
PUBO
PUBLISHED FOR OPPOSITION
12/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/03/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/03/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
09/03/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/03/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
09/03/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/01/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/09/2021
GNRT
NON-FINAL ACTION E-MAILED
27/09/2021
CNRT
NON-FINAL ACTION WRITTEN
27/09/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
23/08/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/12/2020
GNSL
LETTER OF SUSPENSION E-MAILED
03/12/2020
CNSL
SUSPENSION LETTER WRITTEN
03/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/11/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/08/2020
GNRT
NON-FINAL ACTION E-MAILED
20/08/2020
CNRT
NON-FINAL ACTION WRITTEN
20/08/2020
DOCK
ASSIGNED TO EXAMINER
19/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/06/2020
NWAP
NEW APPLICATION ENTERED
23/05/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AIVIVA BIOPHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.